About Julie Friedman

VP, Therapeutics Operations & Program Management
Julie has joined Endpoint Health from Iconic Therapeutics, where she was VP of Operations, Alliance & PM. She brings 30+ years of experience at both small and large pharma/biotech companies, managing programs from lead Candidate Identification through commercial launch while at Medivation, Genentech, Takeda, and Bristol-Myers-Squibb. Julie co-led the successful filing for Medivation’s Extandi® sNDA. She also managed major alliances at Quark, Medivation and Genentech with Roche, Biocon, Astellas and Merk Serono.